Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibing Wang

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Molecular and Clinical Oncology|March 31, 2018
Oxidative stress response induced by chemotherapy in leukemia treatmentJin Zhang, Wen Lei, Xiaohui Chen, et al.
Journal of Neurochemistry|July 19, 2025
Status and Prospects of Glioblastoma Multiforme TreatmentsXue Yang, Shibing Wang, Vedrana Montana, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
High pressure chemistry in the H2-SiH4 systemShibing Wang, Ho-kwang Mao, Xiao-Jia Chen, et al.
Oncotarget|November 16, 2017
<i>ING4</i> expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancerYinfang Wu, Xiaozhou Mou, Shibing Wang, et al.
Oncology Letters|August 28, 2019
Identification of CD206 as a potential biomarker of cancer stem-like cells and therapeutic agent in liver cancerWeimin Fan, Xue Yang, Fang Huang, et al.
Oncology Letters|April 11, 2024
Assessment and prognostic significance of a serum cytokine panel in diffuse large B‑cell lymphomaShufang Xie, Lifen Zhu, Lei Wang, et al.
Oncology Letters|February 6, 2019
Expression of coxsackie and adenovirus receptor is correlated with inferior prognosis in liver cancer patientsXue Yang, Shuangshuang Li, Huiju Wang, et al.
Molecular Medicine Reports|February 17, 2015
Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancerXiujun Han, Shibing Wang, Wenjing Zhou, et al.
Oncotargets and Therapy|February 29, 2020
Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in LymphomaPeng Wang, Yi Wu, Chen Yang, et al.
Journal of Nanobiotechnology|January 22, 2022
Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapyWen Lei, Chen Yang, Yi Wu, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Molecular and Clinical Oncology|March 31, 2018
Oxidative stress response induced by chemotherapy in leukemia treatmentJin Zhang, Wen Lei, Xiaohui Chen, et al.
Journal of Neurochemistry|July 19, 2025
Status and Prospects of Glioblastoma Multiforme TreatmentsXue Yang, Shibing Wang, Vedrana Montana, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
High pressure chemistry in the H2-SiH4 systemShibing Wang, Ho-kwang Mao, Xiao-Jia Chen, et al.
Oncotarget|November 16, 2017
<i>ING4</i> expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancerYinfang Wu, Xiaozhou Mou, Shibing Wang, et al.
Oncology Letters|August 28, 2019
Identification of CD206 as a potential biomarker of cancer stem-like cells and therapeutic agent in liver cancerWeimin Fan, Xue Yang, Fang Huang, et al.
Oncology Letters|April 11, 2024
Assessment and prognostic significance of a serum cytokine panel in diffuse large B‑cell lymphomaShufang Xie, Lifen Zhu, Lei Wang, et al.
Oncology Letters|February 6, 2019
Expression of coxsackie and adenovirus receptor is correlated with inferior prognosis in liver cancer patientsXue Yang, Shuangshuang Li, Huiju Wang, et al.
Molecular Medicine Reports|February 17, 2015
Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancerXiujun Han, Shibing Wang, Wenjing Zhou, et al.
Oncotargets and Therapy|February 29, 2020
Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in LymphomaPeng Wang, Yi Wu, Chen Yang, et al.
Journal of Nanobiotechnology|January 22, 2022
Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapyWen Lei, Chen Yang, Yi Wu, et al.
Pageof 7